AARTIDRUGS Q1 FY27 results at a glance
AARTI DRUGS LTD. Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹703 cr |
|---|
| Revenue YoY | +19.0% |
|---|
| Operating profit | ₹79.74 cr |
|---|
| Operating margin | 11.3% |
|---|
| Net profit | ₹50.17 cr |
|---|
| Net profit YoY | -6.9% |
|---|
| Net profit QoQ | -9.1% |
|---|
| Net margin | 7.1% |
|---|
| Basic EPS | ₹5.49 |
|---|
| TTM revenue | ₹2,678 cr |
|---|
| TTM net profit | ₹191 cr |
|---|
| TTM net margin | 7.1% |
|---|
AARTIDRUGS Q1 FY27 results: what the numbers say
AARTI DRUGS LTD. (AARTIDRUGS) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹703 cr and a net profit of ₹50.17 cr, translating into earnings per share of ₹5.49.
Compared with the same quarter a year earlier, revenue grew by +19.0% and net profit declined by -6.9%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹79.74 cr, an operating margin of 11.3% versus 10.1% a year ago — a gain of 1.3 percentage points.
AARTIDRUGS quarter-wise results table
Net profit
₹50.17 cr
-6.9% YoY
Operating profit
₹79.74 cr
+34.3% YoY
AARTI DRUGS LTD. (AARTIDRUGS) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹703 cr | ₹79.74 cr | ₹50.17 cr | 11.3% | 7.1% | ₹5.49 | -6.9% | -9.1% |
| Q4 FY262026-03-31 | ₹720 cr | ₹77.76 cr | ₹55.19 cr | 10.8% | 7.7% | ₹6.05 | — | +36.1% |
| Q3 FY262025-12-31 | ₹602 cr | ₹37.09 cr | ₹40.54 cr | 6.2% | 6.7% | ₹4.44 | — | -10.5% |
| Q2 FY262025-09-30 | ₹653 cr | ₹68.03 cr | ₹45.28 cr | 10.4% | 6.9% | ₹4.95 | — | -16.0% |
| Q1 FY262025-06-30 | ₹591 cr | ₹59.36 cr | ₹53.91 cr | 10.1% | 9.1% | ₹5.91 | — | — |
| TTM (last 4 quarters) | ₹2,678 cr | ₹263 cr | ₹191 cr | 9.8% | 7.1% | ₹20.93 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
AARTIDRUGS quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
AARTI DRUGS LTD. quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹703 cr | ₹720 cr | ₹602 cr | ₹653 cr | ₹591 cr |
|---|
| Total expenses | ₹623 cr | ₹643 cr | ₹565 cr | ₹585 cr | ₹531 cr |
|---|
| Gross profit | ₹275 cr | ₹270 cr | ₹215 cr | ₹245 cr | ₹217 cr |
|---|
| Operating profit (EBIT) | ₹79.74 cr | ₹77.76 cr | ₹37.09 cr | ₹68.03 cr | ₹59.36 cr |
|---|
| Operating margin | 11.3% | 10.8% | 6.2% | 10.4% | 10.1% |
|---|
| Interest cost | ₹9.22 cr | ₹8.16 cr | ₹9.29 cr | ₹7.7 cr | ₹8.56 cr |
|---|
| Profit before tax | ₹69.24 cr | ₹70.36 cr | ₹29.02 cr | ₹60.41 cr | ₹51.11 cr |
|---|
| Tax expense | ₹19.11 cr | ₹15.1 cr | -₹11.53 cr | ₹15.25 cr | -₹2.86 cr |
|---|
| Effective tax rate | 27.6% | 21.5% | -39.7% | 25.2% | -5.6% |
|---|
| Net profit (PAT) | ₹50.17 cr | ₹55.19 cr | ₹40.54 cr | ₹45.28 cr | ₹53.91 cr |
|---|
| Net profit margin | 7.1% | 7.7% | 6.7% | 6.9% | 9.1% |
|---|
| Basic EPS | ₹5.49 | ₹6.05 | ₹4.44 | ₹4.95 | ₹5.91 |
|---|
| Diluted EPS | ₹5.49 | ₹6.05 | ₹4.44 | ₹4.95 | ₹5.91 |
|---|
AARTIDRUGS results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +19.0% | — | — | — | — |
|---|
| Revenue QoQ | -2.4% | +19.7% | -7.8% | +10.5% | — |
|---|
| Operating profit YoY | +34.3% | — | — | — | — |
|---|
| Operating profit QoQ | +2.5% | +109.7% | -45.5% | +14.6% | — |
|---|
| Net profit YoY | -6.9% | — | — | — | — |
|---|
| Net profit QoQ | -9.1% | +36.1% | -10.5% | -16.0% | — |
|---|
| EPS YoY | -7.1% | — | — | — | — |
|---|
| EPS QoQ | -9.3% | +36.3% | -10.3% | -16.2% | — |
|---|
AARTIDRUGS annual results history
Full-year performance for AARTI DRUGS LTD., useful for reading each quarter in context.
AARTI DRUGS LTD. annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹2,521 cr | ₹2,369 cr | ₹2,509 cr | ₹2,706 cr |
|---|
| Total expenses | ₹2,268 cr | ₹2,126 cr | ₹2,231 cr | ₹2,439 cr |
|---|
| Gross profit | ₹506 cr | ₹479 cr | ₹851 cr | ₹483 cr |
|---|
| Operating profit (EBIT) | ₹253 cr | ₹243 cr | ₹278 cr | ₹266 cr |
|---|
| Operating margin | 10.0% | 10.3% | 11.1% | 9.8% |
|---|
| Interest cost | ₹33.71 cr | ₹35.87 cr | ₹33.52 cr | ₹33.29 cr |
|---|
| Profit before tax | ₹211 cr | ₹212 cr | ₹236 cr | ₹224 cr |
|---|
| Tax expense | ₹15.96 cr | ₹43.67 cr | ₹63.94 cr | ₹57.82 cr |
|---|
| Effective tax rate | 7.6% | 20.6% | 27.1% | 25.8% |
|---|
| Net profit (PAT) | ₹195 cr | ₹168 cr | ₹171 cr | ₹166 cr |
|---|
| Net profit margin | 7.7% | 7.1% | 6.8% | 6.1% |
|---|
| Basic EPS | ₹21.36 | ₹18.35 | ₹18.56 | ₹17.97 |
|---|
| Diluted EPS | ₹21.36 | ₹18.35 | ₹18.56 | ₹17.97 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹703 cr against ₹591 cr in Q1 FY26, and ₹720 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue declined -2.4%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹623 cr, or 88.7% of revenue, with operating profit grew +34.3% year on year.
Margins, tax and profitability
Net profit of ₹50.17 cr works out to a net margin of 7.1% compared with 9.1% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, AARTI DRUGS LTD. reported profit before tax of ₹69.24 cr, a tax charge of ₹19.11 cr (effective rate 27.6%), interest cost of ₹9.22 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹55.19 cr in Q4 FY26 to ₹50.17 cr in Q1 FY27, a change of -9.1%.
Trailing twelve months and annual context
Across the trailing four quarters AARTI DRUGS LTD. has generated revenue of ₹2,678 cr and net profit of ₹191 cr, a trailing net margin of 7.1%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹2,521 cr with net profit of ₹195 cr and EPS of ₹21.36, versus the prior year where revenue grew +6.4% and profit grew +15.9%.
What to watch in the next AARTIDRUGS quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
AARTI DRUGS LTD. has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
AARTIDRUGS results coverage
No results report published for AARTIDRUGS yet — our desk covers each quarter within minutes of the filing.
AARTIDRUGS quarterly results FAQs
What were AARTI DRUGS LTD. (AARTIDRUGS) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), AARTI DRUGS LTD. reported revenue of ₹703 cr and net profit of ₹50.17 cr, a change of -6.9% year on year on +19.0% revenue growth. EPS stood at ₹5.49.
What is AARTIDRUGS profit margin in Q1 FY27?
AARTI DRUGS LTD. posted a net profit margin of 7.1% and an operating margin of 11.3% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹2,678 cr and net profit ₹191 cr.
Did AARTIDRUGS results beat the previous quarter?
AARTI DRUGS LTD. net profit changed -9.1% quarter on quarter, from ₹55.19 cr in Q4 FY26 to ₹50.17 cr in Q1 FY27.
When are AARTI DRUGS LTD. (AARTIDRUGS) quarterly results?
AARTI DRUGS LTD. has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see AARTIDRUGS latest quarterly results?
Results coverage for AARTIDRUGS will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the AARTIDRUGS stock page.
What is AARTI DRUGS LTD. annual revenue and profit?
For FY26, AARTI DRUGS LTD. reported full-year revenue of ₹2,521 cr and net profit of ₹195 cr, with EPS of ₹21.36.
How many quarterly results has AARTIDRUGS declared recently?
Past results dates for AARTIDRUGS will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
